NCT01438580 - The Effect and Safety of Different Intensity Anticoagulation Therapy in Elderly Patients With Non-valvular Atrial Fibrillation | Biotech Hunter

Enrollment

260

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

January 31, 2012

Study Completion Date

April 30, 2012

Conditions

Atrial Fibrillation

Interventions

DRUG

Warfarin

Patients randomised to receive warfarin were initiated on treatment at the baseline dose of 1.25mg daily and then gradually increase the amount to the target INR range.

DRUG

aspirin

100mg aspirin was administrated every day

Trial Locations (1)

210029

First Affiliated Hospital of Nanjing Medical University, Division of Geriatrics, Nanjing